SCHEMBL21395738

SCHEMBL21395738

N#Cc1ccc2oc3ccc(-c4nc(-c5ccc6oc7ccc(C#N)cc7c6c5)nc(-c5ccc6oc7ccc(C#N)cc7c6c5)n4)cc3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.43
PGR P06401 2/20 0.43
TNKS O95271 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
ALDH1A1 P00352 4/20 0.39
MAP4K4 O95819 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CLK4 Q9HAZ1 3/20 0.39
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
APP P05067 1/20 0.37
MEN1 O00255 3/20 0.37
CYP1A2 P05177 3/20 0.37
KMT2A Q03164 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396136 0.92 ALDH1A1 (0.47) CYP2A6PGRTNKSALDH1A1KDM4E
SCHEMBL21395736 0.92 ALDH1A1 (0.47) CYP2A6PGRTNKSALDH1A1KDM4E
SCHEMBL21342517 0.91 MEN1 (0.46) CYP2A6PGRTNKSALDH1A1MAP4K4
SCHEMBL21395795 0.90 MEN1 (0.45) CYP2A6PGRTNKSALDH1A1KDM4E
SCHEMBL21395933 0.90 MEN1 (0.45) CYP2A6PGRTNKSALDH1A1KDM4E
SCHEMBL20282452 0.89 PGR (0.47) CYP2A6PGRTNKSNOS3NOS1
SCHEMBL20282639 0.89 PGR (0.47) CYP2A6PGRTNKSNOS3NOS1
SCHEMBL21395831 0.89 CYP1A2 (0.47) PGRTNKSALDH1A1MAP4K4KDM4E
SCHEMBL21148271 0.89 CYP1A2 (0.47) PGRTNKSALDH1A1MAP4K4KDM4E
SCHEMBL21396138 0.87 PGR (0.47) PGRTNKSALDH1A1KDM4ECLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 CYP2A6 1105/4885PGR 1369/4885TNKS 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.